Turning Point Benefit Group’s AB InBev BUD Stock Holding History

Turning Point Benefit Group’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-99	Closed	-$6.34K	–	194
2025 Q4	$6.34K	Buy	+99	New	+$6.14K	﹤0.01%	272

Other funds holding BUD

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $31.7B AUM 20.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Turning Point Benefit Group's BUD Position: Q1 2026 in Review

Turning Point Benefit Group sold out of AB InBev (BUD) in Q1 2026, closing a stake of 99 shares — an estimated $6.34K sold.

Turning Point Benefit Group first reported a position in BUD in Q4 2025 and held it in 1 quarter. The position peaked at $6.34K in Q4 2025. 544 funds tracked by Wall St. Rank hold BUD as of Q1 2026.

Turning Point Benefit Group reported no remaining AB InBev position as of Q1 2026 after selling out during the quarter.
Turning Point Benefit Group sold 99 AB InBev shares in Q1 2026, an estimated $6.34K.
Turning Point Benefit Group first reported a position in AB InBev in Q4 2025 and held it in 1 quarter.
Turning Point Benefit Group's AB InBev position peaked at $6.34K in Q4 2025.
544 funds tracked by Wall St. Rank held AB InBev as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.